What is "gemox"

GemOx or GEMOX is an acronym for one of the chemotherapy regimens, used in the treatment of relapsed or primary refractory non-Hodgkin's lymphoma and Hodgkin disease.

When combined with Rituximab it is called R-GemOx, R-GEMOX or GemOx-R, GEMOX-R.

The [R]-GemOx regimen consists of:

1. (R)ituximab - anti-CD20 monoclonal antibody that has the ability to kill both normal and malignant B cells;
2. (Gem)citabine - an antimetabolite;
3. (Ox)aliplatin - a platinum-based antineoplastic agent with alkylating mechanism of action.